L
Lloyd D. Fisher
Researcher at University of Washington
Publications - 210
Citations - 29201
Lloyd D. Fisher is an academic researcher from University of Washington. The author has contributed to research in topics: Coronary artery disease & Angina. The author has an hindex of 72, co-authored 210 publications receiving 28231 citations. Previous affiliations of Lloyd D. Fisher include Washington University in St. Louis & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
Greg Brown,John J. Albers,Lloyd D. Fisher,Susan M. Schaefer,Jiin Tarng Lin,Cheryl Kaplan,Xue Qiao Zhao,B. Bisson,Virginia F. Fitzpatrick,Harold T. Dodge +9 more
TL;DR: In men with coronary artery disease who were at high risk for cardiovascular events, intensive lipid-lowering therapy reduced the frequency of progression of coronary lesions, increased the frequencyof regression, and reduced the incidence of cardiovascular events.
Journal ArticleDOI
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.
Salim Yusuf,Salim Yusuf,David M. Zucker,David M. Zucker,E Passamani,P Peduzzi,T Takaro,Lloyd D. Fisher,J W Kennedy,Kathryn B. Davis,T Killip,Norris R,C Morris,V Mathur,Varnauskas Ed,Thomas C. Chalmers +15 more
TL;DR: A strategy of initial CABG surgery is associated with lower mortality than one of medical management with delayed surgery if necessary, especially in high-risk and medium- risk patients with stable coronary heart disease, and in low-risk patients, the limited data show a non-significant trend towards greater mortality with CABGs.
Journal ArticleDOI
Continual reassessment method: a practical design for phase 1 clinical trials in cancer.
TL;DR: A new approach to the design and analysis of Phase 1 clinical trials in cancer and a particularly simple model is looked at that enables the use of models whose only requirements are that locally they reasonably well approximate the true probability of toxic response.
Book
Biostatistics: A Methodology for the Health Sciences
Lloyd D. Fisher,Gerald van Belle +1 more
TL;DR: Partial table of contents: Biostatistical Design of Medical Studies, Descriptive Statistics.
Journal ArticleDOI
Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients
George B. McDonald,Mary S. Hinds,Lloyd D. Fisher,Howard G. Schoch,John L. Wolford,Banaji M,Barbara J. Hardin,Howard M. Shulman,Reginald A. Clift +8 more
TL;DR: The clinical impression is that the current incidence of VOD at the institution is much higher than the 21% rate reported 9 years ago and that more patients have severe liver disease, which may explain the apparent increased incidence and severity of this complication.